Convertible notes payable, net of unamortized discount
317,189
-
-
20,000
Financed payable
18,059
-
-
-
Financing liability
-
31,601
-
-
Accrued interest on convertible notes payable
5,834
-
-
-
Accrued interest
-
83,400
69,960
57,026
Accrued interest - related parties
92,431
-
-
-
Accounts payable and accrued expenses
116,916
116,641
247,852
366,899
Accrued compensation and related expenses
484,392
703,328
754,360
781,392
Tax reimbursement policy liabilities (note 8)
1,646,487
-
-
-
Advances from related parties
84,137
84,137
84,137
84,137
Sba loan
48,750
48,750
48,750
48,750
Total current liabilities
2,814,195
1,067,857
1,205,059
1,358,204
Warrant liabilities
212,364
-
-
-
Total liabilities
3,026,559
1,067,857
1,205,059
1,358,204
Preferred stock, value
1,911
1,911
1,911
2,061
Common stock, 0.001 par value 300,000,000 shares authorized 36,675,786 and 30,175,763 shares issued and outstanding at june 30, 2026 and september 30, 2025, respectively
36,410
35,707
34,182
29,927
Common stock to be issued, 0.001 par value 265,666 and 0 shares to be issued at june 30, 2026 and september 30, 2025, respectively
266
-
-
-
Additional paid-in capital
27,302,718
26,570,440
25,974,173
25,148,936
Less series b preferred stock held in treasury, at cost 502,512 shares at june 30, 2026 and september 30, 2025, respectively
300,000
300,000
300,000
300,000
Accumulated deficit
-29,755,621
-27,199,153
-26,769,586
-26,193,306
Total stockholders' deficit
-2,714,316
-891,095
-1,059,320
-1,312,382
Total liabilities and stockholders' deficit
312,243
176,762
145,739
45,822
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.